These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35346357)

  • 1. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
    Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC
    Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
    Lee IH; Ahn DJ
    Medicine (Baltimore); 2020 May; 99(21):e20228. PubMed ID: 32481295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
    Menghoum N; Oriot P; Hermans MP; Mariage JL
    Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
    Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
    J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
    Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
    J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.
    Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ
    Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
    Dull RB; Spangler ML; Knezevich EL; Lau BM
    J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Allison R; Goldstein D; Musso MW
    J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.
    Branco A; Fatima R; Liblik K; Jackson R; Payne D; El-Diasty M
    J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3877-3886. PubMed ID: 35863986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath SD; Kumar U; Shrivastava V
    Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor.
    Jeong SH; Vorachitti M; Fuentes F
    Cureus; 2023 May; 15(5):e39012. PubMed ID: 37378199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
    Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
    Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic diabetic ketoacidosis following traumatic brain injury.
    Jang SW; Lee H
    Am J Emerg Med; 2024 Mar; 77():232.e1-232.e3. PubMed ID: 38216364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.